ERBB2 and breast carcinoma: Our study found that histogram parameters of MD and MK from non-Gaussian diffusion maps can be used as potential biomarkers for differentiating HER2-positive subtypes and further for identifying the HR status and lymph node metastasis status in HER2-positive breast cancers.